Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

44.05
BATS BZX Real-Time Price
As of 1:01pm ET
 +0.13 / +0.30%
Today’s Change
31.96
Today|||52-Week Range
55.99
+12.69%
Year-to-Date
Abbott's Alere Deal Continues To Face Uncertainty
Jul 20 / TheStreet.com - Paid Partner Content
Alere Updates on 10K Filing, Reports Preliminary Q1 Figures
Jul 15 / Zacks.com - Paid Partner Content
The Reason Behind Alere Inc.'s Double-Digit Percentage Gain on Friday
Jul 15 / MotleyFool.com - Paid Partner Content
Why is Alere Inc. (ALR) up Today?
Jul 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close43.92
Today’s open43.76
Day’s range43.75 - 44.05
Volume17,461
Average volume (3 months)1,241,475
Market cap$3.8B
Dividend yield--
Data as of 1:01pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)+87.61%
Earnings growth (this year)+6.21%
Earnings growth (next 5 years)+8.30%
Revenue growth (last year)-14.61%
P/E ratioNM
Price/Sales1.22
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp+0.41+0.37%
MYGNMyriad Genetics Inc-0.01-0.03%
NEOGNeogen Corp+0.15+0.28%
AAAPAdvanced Accelerator...-0.04-0.13%
Data as of 1:00pm ET, 07/26/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$2.6B
Annual profit (last year)$9.9M
Net profit margin-6.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Namal Nawana
Senior Vice President-
Global Operations
Mark Gladwell
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs